What Montavit does

Montavit, legally Pharmazeutische Fabrik Montavit Ges.m.b.H., is a third-generation family-owned pharmaceutical manufacturer headquartered in Absam, Tyrol, Austria, founded in 1945. The company researches, develops, and produces a proprietary portfolio of branded pharmaceutical products across six therapeutic areas: urology (Cathejell catheter lubricants, Inkontan for incontinence, Utipro plus AF for urinary tract infections), gynaecology (Gellic intimate moisturizer), skin and allergies (Dermodrin, Dibondrin line), respiratory tract (Taviforte, Tavipec, Tavituss), recovery and sleep (Calmaben), travel medicine (Neo Emedyl), and digestive system (Cynarix artichoke-based tablets, Tasectan gelatin tannate for diarrhea). The product line spans multiple dosage forms including capsules, coated tablets, syrups, ointments, ampoules, and sterile gels, with proprietary formulations such as a 600mg artichoke extract tablet (highest-dosed in Austria per company claim) and a combined lidocaine/chlorhexidine catheter gel.

The business operates two revenue streams. The primary stream is the sale of Montavit's own pharmaceutical brands through pharmacy distribution in Austria and internationally across 80+ countries, with owned subsidiaries in Bulgaria (montavit.bg) and Romania (montavit.ro) supporting Eastern European distribution. The secondary stream is pharmaceutical contract manufacturing for well-known pharmaceutical companies from the Absam facility, a capability Montavit has run for decades. Distribution is sales-led, routed through pharmacy networks, with marketing support across website, YouTube, Facebook, Instagram, LinkedIn, XING, and industry trade events. Pricing is not publicly disclosed; products are sold through pharmacies as either prescription or OTC medicines depending on the SKU.

Montavit is led by Managing Directors Mag. Katherina Schmidt and Martin Schröckenfuchs. The company is privately held with no disclosed parent, investor, or funding history, and financials are not publicly reported. Recognized as a Top Arbeitgeber in the Austrian pharma sector in 2020 and 2021 and as a kununu Top Company in 2022, Montavit presents as a stable, multi-generational specialty pharmaceutical manufacturer with a diversified therapeutic portfolio, international pharmacy reach, and a long-running B2B contract manufacturing business as the two main commercial pillars.

Name

Montavit

Legal name

Pharmazeutische Fabrik Montavit Ges.m.b.H.

Website

https://montavit.com

Company type

Private

Founded year

1945

Operating status

Operating

Headcount range

101–250 employees

Short description

Montavit is a third-generation, family-owned Austrian pharmaceutical manufacturer founded in 1945, producing proprietary branded medicines across urology, gynaecology, allergy, respiratory, digestive, and travel health, distributed via pharmacies in 80+ countries alongside a contract manufacturing business.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

akta.pro primary industry

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC), Pediatric OTC Medicines (HLAIADAL)

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medicines
• Herbal remedies
• Contract manufacturing
• Urology products

Headquarters

HQ city

Absam

HQ country

Austria

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Proprietary Pharmaceutical Products: Development, production and sale of Montavit's own pharmaceutical brand products across therapeutic areas including urology, gynaecology, allergy, respiratory, digestive system, and travel medicine. Products are distributed through pharmacies and available in over 80 countries worldwide.
2. Contract Manufacturing: Pharmaceutical contract manufacturing services for well-known pharmaceutical companies. Montavit has been producing for numerous pharmaceutical companies for decades from their facility in Absam, Austria.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

Montavit is a family-owned pharmaceutical manufacturer that develops, produces, and distributes proprietary pharmaceutical products across therapeutic areas including urology, gynecology, allergy treatment, respiratory health, digestive health, and travel medicine, available in 80+ countries through pharmacy distribution. The company also provides pharmaceutical contract manufacturing services from its Absam, Austria facility to other pharmaceutical companies.

Product overview

Montavit is a family-owned pharmaceutical company based in Absam, Tyrol, Austria, operating since 1945. The company operates as a single-brand pharmaceutical manufacturer rather than a platform-plus-modules architecture. Their product portfolio spans six therapeutic areas: respiratory tract products (Taviforte capsules, Tavipec capsules, Tavituss cough syrup), recovery and sleep (Calmaben coated tablets), women's health (Gellic tube lubricating gel), urinary tract (Cathejell catheter lubricant gels in multiple formulations, Inkontan coated tablets, Utipro plus AF capsules), skin and allergies (Dermodrin ointment, Dibondrin in ampoules, coated tablets, and liquid forms), and digestive system (Cynarix and Cynarix FORTE artichoke-based tablets, Tasectan capsules and powder for diarrhea treatment). Additionally, Montavit offers travel medicine products (Neo Emedyl coated tablets). The company also provides pharmaceutical contract manufacturing services for other pharmaceutical companies. Products are available in over 80 countries worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• Taviforte capsules Respiratory tract product in capsule form for treating airway conditions; distributed through pharmacies.
• Tavipec capsules Respiratory tract capsule product for treating airway conditions; distributed through pharmacies.
• Tavituss cough syrup Cough syrup for respiratory tract treatment; distributed through pharmacies.
• Calmaben coated tablets Sleep aid coated tablets containing diphenhydramine; hormone-free and vegan formulation for recovery and sleep support.
• Gellic tube Lubricating gel for women's health; hormone-free intimate moisturizer for vaginal dryness.
• Cathejell C Sterile catheter lubricant gel with chlorhexidine for urinary tract catheterisation procedures.
• Cathejell Lidocaine C Catheter lubricant gel with lidocaine and chlorhexidine for pain-relieving urinary tract catheterisation procedures.
• Cathejell Lidocaine Catheter lubricant gel with lidocaine for pain-relieving urinary tract catheterisation procedures.
• Cathejell Mono Catheter lubricant gel without anesthetic or antiseptic for urinary tract catheterisation procedures.
• Inkontan coated tablets Coated tablets for urinary incontinence treatment.
• Utipro plus AF capsules Medical device in capsule form based on plant-based protective film combined with Hibiscus and Propolis for treatment and prevention of urinary tract infections.
• Dermodrin ointment Topical ointment for skin and allergy treatment.
• Dibondrin ampoules Diphenhydramine ampoules for allergy treatment.
• Dibondrin coated tablets Diphenhydramine coated tablets for allergy treatment.
• Dibondrin liquid Diphenhydramine liquid formulation for allergy treatment.
• Neo Emedyl coated tablets Travel medicine product containing dimenhydrinate for motion sickness treatment and prevention.
• Cynarix coated tablets Traditional herbal medicinal product containing 55mg dry extract from artichoke leaves for relief of digestive complaints including bloating, nausea, belching, and flatulence; for adults and adolescents from 12 years.
• Cynarix FORTE coated tablets Traditional herbal medicinal product containing 600mg artichoke extract per tablet, the highest-dosed artichoke product in Austria; supports fat digestion, protects and regenerates the liver, and relieves digestive complaints; for adults and adolescents from 12 years.
• Tasectan capsules Medical device containing 500mg gelatin tannate (porcine origin) for rapid and gentle treatment of acute diarrhea; protects intestinal mucosa via a protective film, neutralizes diarrhea pathogens, and restores normal bowel function within 12 hours; for adults and children 14 years and older.
• Tasectan powder Medical device containing 250mg gelatin tannate (porcine origin) per sachet for treatment of acute diarrhea in children; for children under 3 years (1 sachet every 6 hours) and children 3-14 years (1-2 sachets every 6 hours).
• Pharmaceutical Contract Manufacturing Pharmaceutical contract manufacturing services for well-known pharmaceutical companies from the Absam, Austria facility; decades of experience producing capsules, tablets, syrups, ointments, ampoules, and sterile gels.

Quantifiable outcome

• Tasectan stops acute diarrhoea typically within 12 hours

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCcxJcTr2jqb-afDuVDwXxOQ
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/pharm.-fabrik-montavit
• Instagraminstagram.com/montavit_com

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Montavit